No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancer. [electronic resource]
Producer: 20181217Description: 381-385 p. digitalISSN:- 1464-5491
- Calcitonin -- metabolism
- Carcinoma, Neuroendocrine -- complications
- Diabetes Mellitus, Type 2 -- complications
- Drug Substitution
- Female
- Glucagon-Like Peptides -- analogs & derivatives
- Humans
- Hypoglycemic Agents -- therapeutic use
- Immunoglobulin Fc Fragments -- therapeutic use
- Middle Aged
- Proto-Oncogene Mas
- Recombinant Fusion Proteins -- therapeutic use
- Thyroid Neoplasms -- complications
No physical items for this record
Publication Type: Case Reports; Research Support, Non-U.S. Gov't; Journal Article
There are no comments on this title.
Log in to your account to post a comment.